Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy

Technology appraisal guidance
Reference number: TA117
Published: 24 January 2007

TA117 Hyperparathyroidism - cinacalcet: Appendix A - decision paper presented to the Institute's Guidance Executive

TA117 Hyperparathyroidism - cinacalcet: Appendix A - decision paper presented to the Institute's Guidance Executive

TA117 Hyperparathyroidism - cinacalcet: Appendix A - decision paper presented to the Institute's Guidance Executive
01 July 2013
(101.31 Kb 29 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 28 June 2013